Trusted Resource for Clinical Trials, Protocols & Progress
Social media is not a one-size-fits-all tool. Each platform serves different communities, content formats, and engagement norms. Choosing the right one helps you:
Click to read the full article.
Organic Social Media involves unpaid content posted on platforms like Facebook, Twitter, Instagram, or LinkedIn. It includes status updates, educational infographics, videos, and event promotions shared through your page or group.
Click to read the full article.
Recruitment messaging, even online, is considered part of a clinical trial’s promotional material and is subject to regulatory oversight. Improper practices can lead to:
Click to read the full article.
Traditional recruitment methods like flyers, hospital referrals, and newspaper ads often fall short in today’s media landscape. Social media provides:
Click to read the full article.
Clinical trial participants should reflect the populations most likely to use the treatment. Without adequate representation, sponsors risk:
Click to read the full article.
Challenge: A major oncology sponsor observed disproportionately low enrollment of Black patients in multiple Phase II trials, despite high disease prevalence in African American communities.
Click to read the full article.
Diversity metrics allow stakeholders to measure whether a clinical trial reflects the population it intends to treat. These metrics include race, ethnicity, age, gender, socioeconomic status, and geographic location. Tracking these elements provides insight into:
Click to read the full article.
